
Pharmacognosy Practical D Pharm
1. Morphological Identification of the following drugs:
Ispaghula, Senna, Coriander, Fennel, Cardamom, Ginger, Nutmeg, Black Pepper, Cinnamon, Clove, Ephedra, Rauwolfia, Gokhru, Punarnava, Cinchona, Agar.
2. Gross anatomical studies (Transverse Section) of the following drugs:
Ajwain, Datura, Cinnamon, Cinchona, Coriander, Ashwagandha, Liquorice, Clove, Curcuma, Nux vomica, Vasaka
3. Physical and chemical tests for evaluation of any FIVE of the following drugs:
- Asafoetida,
- Benzoin,
- Pale catechu,
- Black catechu,
- Castor oil,
- Acacia,
- Tragacanth,
- Agar,
- Guar gum,
- Gelatine.
Assignments
The students shall be asked to submit the written assignments on the following topics (One assignment per student per sessional period. i.e., a minimum of THREE assignments per student)
1. Market preparations of various dosage forms of Ayurvedic, Unani, Siddha, Homeopathic (Classical and Proprietary), indications, and their labelling requirements
2. Market preparations of various herbal formulations and herbal cosmetics, indications, and their labelling requirements
3. Herb-Drug interactions documented in the literature and their clinical significance
Field Visit
The students shall be taken in groups to a medicinal garden to witness and understand the nature of various medicinal plants discussed in theory and practical courses. Additionally, they shall be taken in groups to the pharmacies of traditional systems of medicines to understand the availability of various dosage forms and their labelling requirements. Individual reports from each student on their learning experience from the field visit shall be submitted.
F Y D Pharm & S Y D Pharm Notes, Books, Syllabus, PDF, Videos
Suggested readings
Recommended readings:
Amyotrophic Lateral Sclerosis (ALS): Symptoms, Causes, and Advances in Treatment
San Diego, April 8, 2025 – Amyotrophic lateral sclerosis (ALS), often called Lou Gehrig’s disease, is a progressive neurodegenerative disorder that attacks nerve cells responsible for voluntary muscle control. With no known cure and a prognosis of 2–5 years post-diagnosis for most patients, ALS remains one of medicine’s most challenging conditions. Here’s a comprehensive overview of its mechanisms,…
ALS Disease update: NeuroSense’s PrimeC Shows Groundbreaking ALS Results
San Diego, April 8, 2025 – NeuroSense Therapeutics (NASDAQ: NRSN) has announced landmark data from its Phase 2b PARADIGM trial for PrimeC, a novel amyotrophic lateral sclerosis (ALS) therapy, revealing a 33% reduction in disease progression and a 58% improvement in survival rates over 18 months. The findings, presented at the 77th Annual American Academy of Neurology (AAN) Meeting, position…
Karnataka State Pharmacy Council Dissolved Over Irregularities; FDA Commissioner Appointed Administrator
Bengaluru, April 9, 2025 – In a significant move to address years of alleged mismanagement, the Karnataka government has dissolved the Karnataka State Pharmacy Council (KSPC) and appointed the Commissioner of Food Safety and Drug Administration (FDA) as its administrator. The decision follows persistent efforts by the Karnataka Chemists & Druggists Association (KCDA) and a damning…


